Measles vaccination of young infants in China: A cost-effectiveness analysis.

ABSTRACT:

Background

Although global progress in measles control has been realized, achieving elimination has proven difficult in many regions of the world. China has adopted a goal of measles elimination but recent outbreaks predominantly affecting children <8 months who are ineligible for vaccination and incompletely protected by maternal antibodies has impeded progress. We assess the cost-effectiveness of adding an initial measles vaccine dose in China to earlier than the currently recommended 8 months of age.

Methods

We conducted a cost-utility analysis comparing the costs and health benefits associated with adding a measles vaccine dose to the routine schedule at 4, 5, 6 or 7 months compared to the current recommendation for the first dose at age 8 months. A decision analytic mod

SUBMITTER: Janusz CB 

PROVIDER: S-EPMC7920528 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature